Cargando…
Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
Diabetic cardiomyopathy (DCM) is one of the common complications of diabetic patients, which can induce myocardial hypertrophy, cardiac fibrosis, and heart failure. Growing evidence has shown that the occurrence and development of DCM are accompanied by pyroptosis which is an NLRP3-mediated intense...
Autores principales: | Gao, Ge, Fu, Lingyun, Xu, Yini, Tao, Ling, Guo, Ting, Fang, Guanqin, Zhang, Guangqiong, Wang, Shengquan, Qin, Ti, Luo, Peng, Shen, Xiangchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294384/ https://www.ncbi.nlm.nih.gov/pubmed/35865939 http://dx.doi.org/10.3389/fphar.2022.906548 |
Ejemplares similares
-
Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020) -
Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
por: Jia, Qi, et al.
Publicado: (2022) -
NLRP3-mediated pyroptosis in diabetic nephropathy
por: Wan, Jiayi, et al.
Publicado: (2022) -
Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway
por: Chai, Yuhui, et al.
Publicado: (2022) -
Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis
por: Wang, Jianxin, et al.
Publicado: (2023)